State Of Wisconsin Investment Board Phathom Pharmaceuticals, Inc. Transaction History
State Of Wisconsin Investment Board
- $37.8 Billion
- Q3 2024
A detailed history of State Of Wisconsin Investment Board transactions in Phathom Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 81,770 shares of PHAT stock, worth $466,906. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,770
Previous 113,592
28.01%
Holding current value
$466,906
Previous $1.17 Million
26.43%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding PHAT
# of Institutions
147Shares Held
75.3MCall Options Held
42.3KPut Options Held
45.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.1MShares$57.7 Million9.84% of portfolio
-
Medicxi Ventures Management (Jersey) LTD7.46MShares$42.6 Million13.31% of portfolio
-
Jennison Associates LLC7.06MShares$40.3 Million0.04% of portfolio
-
Invesco Ltd. Atlanta, GA4.1MShares$23.4 Million0.01% of portfolio
-
Carlyle Group Inc. Washington, DC3.5MShares$20 Million9.52% of portfolio
About Phathom Pharmaceuticals, Inc.
- Ticker PHAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,175,200
- Market Cap $224M
- Description
- Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also develo...